Ravikiran S Yedidi
4PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 24, 2022
Success of Current COVID-19 Vaccine Strategies vs. the Epitope Topology of SARS-CoV-2 Spike Protein-Receptor Binding Domain (RBD): A Computational Study of RBD Topology to Guide Future Vaccine Design.Santhinissi Addala, Madhuri Vissapragada, Madhumita Aggunna
|Jan 03, 2022
Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors In Vitro.Masayuki Amano, Ravikiran S Yedidi, Pedro Miguel Salcedo-Gómez
|May 08, 2019
Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications.Masayuki Amano, Pedro Miguel Salcedo-Gómez, Ravikiran S Yedidi
|Sep 14, 2016
A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413.Masayuki Amano, Pedro Miguel Salcedo-Gómez, Rui Zhao
Pageof 1
